Valeritas Holdings, Inc. (VLRX) financial statements (2021 and earlier)

Company profile

Business Address 750 ROUTE 202 SOUTH
BRIDGEWATER, NJ 08807
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments47261000
Cash and cash equivalents47261000
Receivables644  
Inventory, net of allowances, customer advances and progress billings78900
Inventory78900
Deferred costs 11 0
Other undisclosed current assets211  
Total current assets:62392400
Noncurrent Assets
Property, plant and equipment6510  
Other noncurrent assets000  
Total noncurrent assets:7610  
TOTAL ASSETS:69453500
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities67600
Accounts payable56500
Accrued liabilities212  
Taxes payable000  
Interest and dividends payable   00
Debt0  00
Deferred compensation liability433  
Due to related parties   00
Deferred revenue and credits22  
Other undisclosed current liabilities421  
Total current liabilities:14131200
Noncurrent Liabilities
Long-term debt and lease obligation0    
Capital lease obligations0    
Liabilities, other than long-term debt, including:0059  
Deferred revenue and credits 0  
Due to related parties403659  
Derivative instruments and hedges, liabilities  0  
Other undisclosed liabilities, other than long-term debt(40)(36)   
Other undisclosed noncurrent liabilities4036   
Total noncurrent liabilities:403659  
Total liabilities:54497100
Stockholders' equity
Stockholders' equity attributable to parent14(4)(37)(0)(0)
Preferred stock00   
Common stock000  
Treasury stock, value(0)(0)   
Additional paid in capital53447038800
Accumulated deficit(520)(474)(424)(0)(0)
Total stockholders' equity:14(4)(37)(0)(0)
TOTAL LIABILITIES AND EQUITY:69453500

Income statement (P&L) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues2620200 
Revenue, net  0 
Cost of revenue
(Cost of Goods and Services Sold)
(14)(12)(13)(0) 
Gross profit:12870 
Operating expenses(55)(53)(41)(0) 
Operating loss:(42)(45)(34)(0) 
Nonoperating expense(4)(4)(13)  
Interest and debt expense(0)(0)(4)(0) 
Loss from continuing operations before equity method investments, income taxes:(46)(49)(51)(0) 
Other undisclosed income from continuing operations before income taxes00   
Net loss:(46)(49)(51)(0) 
Other undisclosed net income (loss) attributable to parent  4(0) 
Net loss attributable to parent:(46)(49)(46)(0) 
Preferred stock dividends and other adjustments(2)(2)   
Net loss available to common stockholders, diluted:(48)(51)(46)(0) 

Comprehensive Income ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(46)(49)(51)(0) 
Comprehensive loss, net of tax, attributable to parent:(46)(49)(51)(0) 

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: